RK

Ratan Kumar Gulati

Active Director Director DIN 09436383
DIN 09436383 First appointment Dec 2021 Primary industry Machinery and Equipment
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ratan Kumar Gulati

Data last updated:

Ratan Kumar Gulati is a Director at Accent Pharmaceuticals And Diagnostics Private Limited (since 2021). The company operates in Machinery and Equipment.

DIN 09436383
Primary Designation Director
Industry Machinery and Equipment
First Appointment 15 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Dec 20212021Active

Board colleagues of Ratan Kumar Gulati

Directorship timeline

Open interactive timeline →
Accent Pharmaceuticals And Diagnostics Private Limited
Premium access

Shareholding and investment profile for Ratan Kumar Gulati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ratan Kumar Gulati

Ratan Kumar Gulati currently holds 1 directorship: Accent Pharmaceuticals And Diagnostics Private Limited (Director, since 15 Dec 2021).

Ratan Kumar Gulati was first appointed on 15 Dec 2021 as Director at Accent Pharmaceuticals And Diagnostics Private Limited.

The current boards of Ratan Kumar Gulati's companies include Hitesh Manocha (Accent Pharmaceuticals And Diagnostics Private Limited), Puneet Manocha (Accent Pharmaceuticals And Diagnostics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available